Statistics for FibroGen (id:7618 FGEN)

Valuation metrics

Market cap

33.73M

Enterprise value

103.85M

Trailing P/E (ttm)

-0.14

Forward P/E

-0.49

PEG ratio

-0.49

Price/Sales (ttm)

0.19

Price/Book (mrq)

-0.21

Enterprise Value/Revenue

0.60

Enterprise Value/EBITDA

-0.63

Overview

Shares outstanding

100.77M

Float

90.52M

Shares short

4.32M

% Held by insiders

0.01%

% Held by institutions

0.55%

Average volume (10 days)

1.75M

Average volume (90 days)

Price summary

52-Week low

0.18

52-Week high

2.93

52-Week change

-11.90%

Beta

0.73

50-Day moving average

0.36

200-Day moving average

1.05

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-96.84%

Operating margin

-21.56%

Operational effectiveness

Return on assets

-26.55%

Return on equity

175.24%

Income statement

Revenue (ttm)

1.76

Revenue per share (ttm)

1.76

Quarterly revenue growth (yoy)

Gross profit (ttm)

128.90M

EBITDA

-165,835,008.00

Net income to common (ttm)

-168,324,000.00

Diluted EPS (ttm)

-1.23

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

140.71M

Total cash per share (mrq)

1.40

Total debt (mrq)

163.78M

Total Debt/Equity (mrq)

-0.86

Current ratio (mrq)

141.00%

Book value per share (mrq)

-2.07

Cash flow

Cash flow statement

-202,016,000.00

Levered free cash flow (LFCF)

-121,833,376.00